A landscape analysis of psychedelic retreat organizations advertising online
Nikita Singh, Srijith Kambala, Logan Neitzke-Spruill, Caroline Beit, Jill O. Robinson, Rashmi Ramesh, Amy L. Mcguire
PLoS One May 2, 2025 DOI: 10.1371/journal.pone.0321648 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Landscape analysis Peer reviewed |
|---|---|
| Sample size | 298 |
| Population | Organizations offering psychedelic retreats and marketing to English-speaking consumers |
| Duration | July 2023 to December 2023 |
| Topics | Psilocybin |
| Keywords | Globe Harm Public relations Hallucinogen Advertising |
| Citations | 10 |
| Key points | The psychedelic retreat industry includes 298 organizations offering various substances, primarily ayahuasca, at 440 locations worldwide, with most focusing on general wellness. |
Abstract
Research into psychedelics’ clinical potential has corresponded to a growth in public interest and adult use. One common pathway to accessing psychedelics is through psychedelic retreats. While individual retreats have been characterized in the anthropological literature, no systematic evaluation of the psychedelic retreat industry exists. Assessing the characteristics of the psychedelic retreat industry is critical to understanding the associated ethical, legal, and social implications and ensuring consumer safety. To this end, we conducted a landscape analysis of online, publicly available information to capture and characterize a broad range of organizations offering psychedelic retreats and marketing to English-speaking consumers. From July 2023 to December 2023, we identified 298 psychedelic retreat organizations. Some identified as religious organizations, but the majority focused on general wellness. Organizations offered various psychedelic substances with ayahuasca being the most common, followed by psilocybin and San Pedro. Organizations held retreats across the globe at various price points. In total, there were 440 distinct physical locations where retreat experiences were held; 130 were inside the United States (U.S.) and 310 were outside the U.S. Further research into the practices of psychedelic retreat organizations is recommended to help reduce harm and support consumer education.
Citations in the library
Cited by 10
- The science of psychedelic medicine. Nature Medicine February 6, 2026
- Reported Safety Practices of Publicly Advertised Psychedelic Retreats. JAMA Network Open January 2, 2026
- Addressing US Demand for Psychedelic Medicines in the Face of Scientific Uncertainty. The Journal of Law, Medicine & Ethics 2026
- Becoming a Psychedelic User: Reflections on Howard Becker and the (Future) Sociology of Psychedelics Sociology Compass August 1, 2025
- Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit–Risk Considerations in Policy and Clinical Development Biomolecules July 3, 2026
and 5 more in the library
Cites 53
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
- Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report Brazilian Journal of Psychiatry March 1, 2015
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Journal of Clinical Psychopharmacology December 11, 2015
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Acta Psychiatrica Scandinavica October 30, 2020
- The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion Journal of Psychedelic Studies July 1, 2019
and 48 more in the library